logo
Select company
Select metric
$ -330.15MNet Income Common Stock
VS
Market
4
Sector
5
Industry
6
History
14
$ 12.96Close
$ 2.29 - $ 18.94 52-Week Range
Ticker Information

Ticker

PHAT

Company Name

PHATHOM PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PHATHOM PHARMACEUTICALS INC - Net Income Common Stock Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PHAT - Net Inc. Cmn. Historical data
DateNet Income Common Stock
6/30/2025$ -330.15M
3/31/2025$ -345.79M
12/31/2024$ -334.33M
9/30/2024$ -339.44M
6/30/2024$ -297.11M
3/31/2024$ -246.63M
12/31/2023$ -201.59M
9/30/2023$ -177.07M
6/30/2023$ -184.92M
3/31/2023$ -194.87M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PHATHOM PHARMACEUTICALS INC's latest trailing twelve months (TTM) Net Inc. Cmn. stands at $ -173.35M.
  • Over the past 5 years, PHATHOM PHARMACEUTICALS INC's average Net Inc. Cmn. has been $ -212.65M.
  • The median Net Inc. Cmn. for PHATHOM PHARMACEUTICALS INC during this period was $ -181.71M
  • PHATHOM PHARMACEUTICALS INC reached its highest Net Inc. Cmn. over the past 5 years at $ -129.07M.
  • The lowest Net Inc. Cmn. recorded by PHATHOM PHARMACEUTICALS INC in the same timeframe $ -345.79M

PHATHOM PHARMACEUTICALS INC's Net Inc. Cmn. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Net Inc. Cmn. Benchmarks
CompanyNet Inc. Cmn.
GYRE : GYRE THERAPEUTICS INC $ 4.17MANAB : ANAPTYSBIO INC $ -132.59MNAGE : NIAGEN BIOSCIENCE INC $ 17.73MCRMD : CORMEDIX INC $ 51.16MTBPH : THERAVANCE BIOPHARMA INC $ 13.03MZYME : ZYMEWORKS INC $ -73.67MURGN : UROGEN PHARMA LTD $ -154.97MZVRA : ZEVRA THERAPEUTICS INC $ 2.64MXNCR : XENCOR INC $ -171.08MKURA : KURA ONCOLOGY INC $ -197.17M

Definition of Net Income Common Stock

[Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].

PHAT - Net Income Common Stock, Last 5 years

$ -345.79M

Minimum

Mar 31, 2025

$ -129.07M

Maximum

Dec 31, 2020

$ -212.65M

Average

$ -181.71M

Median

Net Inc. Cmn. Benchmark Analysis

The chart above depicts the distribution of Net Inc. Cmn. for companies in the Total Stock Market. The average Net Inc. Cmn. of the companies is $ 9.27M with a standard deviation of $ 113.61M.
The following table provides additional summary stats:
Net Inc. Cmn. in the Market:
filtered constituents3.37K
min$ -354.46M
max$ 366.43M
average$ 9.27M
median$ -2.46M
std$ 113.61M